跳至主要内容
临床试验/NCT07819526
NCT07819526招募中不适用

Clinical Characteristics and Stroke Recurrence in Patients With Acute Ischemic Stroke and Active Cancer: CAT-AIS Study

Osaka University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2026年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Percentage of Participants With Recurrent Ischemic Stroke Within 3 Months

研究概览

简要总结

The goal of this multicenter prospective observational study, conducted at 24 hospitals in Japan, is to learn about recurrent ischemic stroke in people with active cancer who develop acute ischemic stroke. One of the main objectives is to evaluate how often ischemic stroke recurs during follow-up.

The main questions this study aims to answer are:

  • How often does ischemic stroke recur within 3 months after the initial stroke?
  • Which clinical factors may be associated with recurrent ischemic stroke?
  • What other clinical outcomes occur during follow-up?

Participants will receive medical care determined by their treating physicians. Researchers will collect information about participants' cancer, stroke characteristics, test results, treatments, recurrent ischemic stroke, and other clinical outcomes. Researchers will also explore whether clinical factors are associated with recurrent ischemic stroke and other outcomes. This study will not assign participants to a specific treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Acute ischemic stroke diagnosed within 7 days after symptom onset or the time last known well.
  • Active cancer at the time of the index stroke, as defined below.

排除标准

  • The patient or a legally acceptable representative indicates that the patient does not wish to participate.
  • The investigator considers enrolment inappropriate.

研究组 & 干预措施

Participants with acute ischemic stroke and active cancer

Participants with active cancer who develop acute ischemic stroke and are enrolled prospectively at participating hospitals. Clinical information, treatments, recurrent ischemic stroke, and other outcomes will be collected during follow-up.

结局指标

主要结局

Percentage of Participants With Recurrent Ischemic Stroke Within 3 Months

时间窗: From enrollment through 3 months of follow-up

The percentage of participants who experience recurrent ischemic stroke during follow-up. Recurrent ischemic stroke will be determined according to the criteria prespecified in the study protocol.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验